Pfizer has approached AstraZeneca to propose a 60 billion-pound ($101 billion) takeover, Britain's Sunday Times reported, according to Reuters. The newspaper cited senior investment bankers and industry sources saying that informal ...
Does a recreational drug and horse tranquilizer really have potential as an effective treatment for one of the toughest, and most common, psychiatric illnesses out there?
Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market. Instead of testing one drug at a time, a novel lung cancer study announced on Thursday will allow British researchers to test up to 14 drugs from AstraZeneca and Pfizer (TLO: PF-U.TI - news) at the same time within one trial. The aim is to quickly pinpoint medicines that can fight advanced lung cancer by targeting specific rare genetic mutations - and it upends the normal approach of putting a particular drug at the centre of a study. Harpal Kumar, chief executive of charity Cancer Research UK, which is working on the 25-million-pound ($42-million) project with the two drugmakers, said the new approach would "re-write the rule book on how we do clinical trials".
Glaxo gained approval in the U.S. as an adjunct to diet and exercise in adults suffering from type II diabetes.